{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T22:59:17Z","timestamp":1781218757569,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,11]]},"DOI":"10.7759\/cureus.110688","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T22:52:47Z","timestamp":1781218367000},"source":"Crossref","is-referenced-by-count":0,"title":["A Comprehensive Pan-Cancer Analysis Revealing IGF2 Gene as a Diagnostic and Prognostic Biomarker"],"prefix":"10.7759","author":[{"given":"Wala","family":"Abdallah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman E","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal H. A","family":"Assed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Elrashid Yagoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar","family":"Doleeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Alfaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-23-0411","article-title":"Updating the definition of cancer","volume":"21","author":"Brown JS","year":"2023","unstructured":"Brown JS, Amend SR, Austin RH, Gatenby RA, Hammarlund EU, Pienta KJ. Updating the definition of cancer. Mol Cancer Res. 2023, 21:1142-7. 10.1158\/1541-7786.MCR-23-0411","journal-title":"Mol Cancer Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2017.16","article-title":"New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles","volume":"24","author":"Zaimy MA","year":"2017","unstructured":"Zaimy MA, Saffarzadeh N, Mohammadi A, et al.. New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles. Cancer Gene Ther. 2017, 24:233-43. 10.1038\/cgt.2017.16","journal-title":"Cancer Gene Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a019505","article-title":"Epigenetic determinants of cancer","volume":"8","author":"Baylin SB","year":"2016","unstructured":"Baylin SB, Jones PA. Epigenetic determinants of cancer. Cold Spring Harb Perspect Biol. 2016, 8:10.1101\/cshperspect.a019505","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15347","article-title":"Ancient genes can be served as pan-cancer diagnostic and prognostic biomarkers","volume":"24","author":"Ji X","year":"2020","unstructured":"Ji X, Cui Q. Ancient genes can be served as pan-cancer diagnostic and prognostic biomarkers. J Cell Mol Med. 2020, 24:6908-15. 10.1111\/jcmm.15347","journal-title":"J Cell Mol Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvad202","article-title":"Epidemiology of cancer","volume":"70","author":"Schwartz SM","year":"2024","unstructured":"Schwartz SM. Epidemiology of cancer. Clin Chem. 2024, 70:140-9. 10.1093\/clinchem\/hvad202","journal-title":"Clin Chem"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-13-0231","article-title":"IGF2 and cancer","volume":"20","author":"Livingstone C","year":"2013","unstructured":"Livingstone C. IGF2 and cancer. Endocr Relat Cancer. 2013, 20:R321-39. 10.1530\/ERC-13-0231","journal-title":"Endocr Relat Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/cells11121886","article-title":"IGF2: development, genetic and epigenetic abnormalities","volume":"11","author":"S\u00e9l\u00e9nou C","year":"2022","unstructured":"S\u00e9l\u00e9nou C, Brioude F, Giabicani E, Sobrier ML, Netchine I. IGF2: development, genetic and epigenetic abnormalities. Cells. 2022, 11:1886. 10.3390\/cells11121886","journal-title":"Cells"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113615","article-title":"Insulin receptor isoforms in cancer","volume":"19","author":"Vella V","year":"2018","unstructured":"Vella V, Milluzzo A, Scalisi NM, Vigneri P, Sciacca L. Insulin receptor isoforms in cancer. Int J Mol Sci. 2018, 19:3615. 10.3390\/ijms19113615","journal-title":"Int J Mol Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.19.5.3278","article-title":"Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells","volume":"19","author":"Frasca F","year":"1999","unstructured":"Frasca F, Pandini G, Scalia P, et al.. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol. 1999, 19:3278-88. 10.1128\/MCB.19.5.3278","journal-title":"Mol Cell Biol"},{"key":"ref10","unstructured":"Biofix tool. (2024). Accessed. November 4, 2024: https:\/\/mohamedalfaki.shinyapps.io\/BioFixV5\/."},{"key":"ref11","unstructured":"TIMER. Tumor Immune Estimation Resource. (2017). Accessed: November 4, 2024: https:\/\/cistrome.shinyapps.io\/timer\/."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang Z","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017, 45:W98-W102. 10.1093\/nar\/gkx247","journal-title":"Nucleic Acids Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar DS","year":"2017","unstructured":"Chandrashekar DS, Bashel B, Balasubramanya SA, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BV, Varambally S. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017, 19:649-58. 10.1016\/j.neo.2017.05.002","journal-title":"Neoplasia"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.6004\/jadpro.2016.7.1.8","article-title":"An introduction to survival statistics: Kaplan-Meier analysis","volume":"7","author":"Dudley WN","year":"2016","unstructured":"Dudley WN, Wickham R, Coombs N. An introduction to survival statistics: Kaplan-Meier analysis. J Adv Pract Oncol. 2016, 7:91-100. 10.6004\/jadpro.2016.7.1.8","journal-title":"J Adv Pract Oncol"},{"key":"ref15","unstructured":"cBioPortal for cancer genomics. (2013). Accessed. November 5, 2024: https:\/\/www.cbioportal.org\/."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-23-0816","article-title":"Analysis and visualization of longitudinal genomic and clinical data from the AACR project GENIE Biopharma collaborative in cBioPortal","volume":"83","author":"de Bruijn I","year":"2023","unstructured":"de Bruijn I, Kundra R, Mastrogiacomo B, et al.. Analysis and visualization of longitudinal genomic and clinical data from the AACR project GENIE Biopharma collaborative in cBioPortal. Cancer Res. 2023, 83:3861-7. 10.1158\/0008-5472.CAN-23-0816","journal-title":"Cancer Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk D","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, et al.. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023, 51:D638-46. 10.1093\/nar\/gkac1000","journal-title":"Nucleic Acids Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky311","article-title":"GeneMANIA update 2018","volume":"46","author":"Franz M","year":"2018","unstructured":"Franz M, Rodriguez H, Lopes C, Zuberi K, Montojo J, Bader GD, Morris Q. GeneMANIA update 2018. Nucleic Acids Res. 2018, 46:W60-4. 10.1093\/nar\/gky311","journal-title":"Nucleic Acids Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool","volume":"14","author":"Chen EY","year":"2013","unstructured":"Chen EY, Tan CM, Kou Y, et al.. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013, 14:128. 10.1186\/1471-2105-14-128","journal-title":"BMC Bioinformatics"},{"key":"ref20","unstructured":"The Gene Expression Omnibus database. (2000). Accessed. November 5, 2024: https:\/\/www.ncbi.nlm.nih.gov\/geo\/."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S183085","article-title":"miR-491-5p functions as a tumor suppressor by targeting IGF2 in colorectal cancer","volume":"11","author":"Lu L","year":"2019","unstructured":"Lu L, Cai M, Peng M, Wang F, Zhai X. miR-491-5p functions as a tumor suppressor by targeting IGF2 in colorectal cancer. Cancer Manag Res. 2019, 11:1805-16. 10.2147\/CMAR.S183085","journal-title":"Cancer Manag Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11061655","article-title":"Human IGF2 gene epigenetic and transcriptional regulation: at the core of developmental growth and tumorigenic behavior","volume":"11","author":"Scalia P","year":"2023","unstructured":"Scalia P, Williams SJ, Fujita-Yamaguchi Y. Human IGF2 gene epigenetic and transcriptional regulation: at the core of developmental growth and tumorigenic behavior. Biomedicines. 2023, 11:1655. 10.3390\/biomedicines11061655","journal-title":"Biomedicines"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.718589","article-title":"Aggresome-autophagy associated gene HDAC6 is a potential biomarker in Pan-cancer, especially in colon adenocarcinoma","volume":"11","author":"Zhang Z","year":"2021","unstructured":"Zhang Z, Zhang X, Huang A. Aggresome-autophagy associated gene HDAC6 is a potential biomarker in Pan-cancer, especially in colon adenocarcinoma. Front Oncol. 2021, 11:718589. 10.3389\/fonc.2021.718589","journal-title":"Front Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111107","article-title":"Pan-cancer analysis predicts CANT1 as a potential prognostic, immunologic biomarker","volume":"117","author":"Yang W","year":"2024","unstructured":"Yang W, Liu Z, Liu T. Pan-cancer analysis predicts CANT1 as a potential prognostic, immunologic biomarker. Cell Signal. 2024, 117:111107. 10.1016\/j.cellsig.2024.111107","journal-title":"Cell Signal"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/path.6033","article-title":"Cancer-associated fibroblasts potentiate colorectal cancer progression by crosstalk of the IGF2-IGF1R and Hippo-YAP1 signaling pathways","volume":"259","author":"Zhang J","year":"2023","unstructured":"Zhang J, Chen B, Li H, et al.. Cancer-associated fibroblasts potentiate colorectal cancer progression by crosstalk of the IGF2-IGF1R and Hippo-YAP1 signaling pathways. J Pathol. 2023, 259:205-19. 10.1002\/path.6033","journal-title":"J Pathol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-014-1700-9","article-title":"High IGF2 and FGFR3 are associated with tumour progression in undifferentiated pleomorphic sarcomas, but EGFR and FGFR3 mutations are a rare event","volume":"140","author":"R\u00fcping K","year":"2014","unstructured":"R\u00fcping K, Altendorf-Hofmann A, Chen Y, et al.. High IGF2 and FGFR3 are associated with tumour progression in undifferentiated pleomorphic sarcomas, but EGFR and FGFR3 mutations are a rare event. J Cancer Res Clin Oncol. 2014, 140:1315-22. 10.1007\/s00432-014-1700-9","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-015-1280-4","article-title":"Expression of IMP3 and IGF2 in giant cell tumor of spine is associated with tumor recurrence and angiogenesis","volume":"17","author":"Zhang K","year":"2015","unstructured":"Zhang K, Zhou M, Chen H, Wu G, Chen K, Yang H. Expression of IMP3 and IGF2 in giant cell tumor of spine is associated with tumor recurrence and angiogenesis. Clin Transl Oncol. 2015, 17:570-5. 10.1007\/s12094-015-1280-4","journal-title":"Clin Transl Oncol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3892\/or.2015.4048","article-title":"High IGF2 expression is associated with poor clinical outcome in human ovarian cancer","volume":"34","author":"Dong Y","year":"2015","unstructured":"Dong Y, Li J, Han F, et al.. High IGF2 expression is associated with poor clinical outcome in human ovarian cancer. Oncol Rep. 2015, 34:936-42. 10.3892\/or.2015.4048","journal-title":"Oncol Rep"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1177\/172460080201700203","article-title":"Insulin-like growth factor II (IGF-II) immunohistochemistry in breast cancer: relationship with the most important morphological and biochemical prognostic parameters","volume":"17","author":"Giani C","year":"2002","unstructured":"Giani C, Campani D, Rasmussen A, et al.. Insulin-like growth factor II (IGF-II) immunohistochemistry in breast cancer: relationship with the most important morphological and biochemical prognostic parameters. Int J Biol Markers. 2002, 17:90-5. 10.1177\/172460080201700203","journal-title":"Int J Biol Markers"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1335","article-title":"Insulin-like growth factor 2: a poor prognostic biomarker linked to racial disparity in women with uterine carcinosarcoma","volume":"7","author":"Van Arsdale AR","year":"2018","unstructured":"Van Arsdale AR, Arend RC, Cossio MJ, et al.. Insulin-like growth factor 2: a poor prognostic biomarker linked to racial disparity in women with uterine carcinosarcoma. Cancer Med. 2018, 7:616-25. 10.1002\/cam4.1335","journal-title":"Cancer Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/420017-a-comprehensive-pan-cancer-analysis-revealing-igf2-gene-as-a-diagnostic-and-prognostic-biomarker","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T22:52:49Z","timestamp":1781218369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/420017-a-comprehensive-pan-cancer-analysis-revealing-igf2-gene-as-a-diagnostic-and-prognostic-biomarker"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.110688","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,11]]}}}